ASX
Mesoblast Limited
MSB:ASX•Healthcare
Sensitive ASX Announcement
FDA Clearance for Phase 2 Clinical Trial in Type 2 Diabetes
Published: 31/01/12, 11:09am (AEST)•2 pages